Daratumumab induced lichenoid drug eruption. [PDF]
Perz C, Wissman T, Montebello A.
europepmc +1 more source
Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 study. [PDF]
Yang W +17 more
europepmc +1 more source
Smoldering multiple myeloma in transition: redefining early myeloma in the modern era. [PDF]
Landgren O.
europepmc +1 more source
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies. [PDF]
Cavo M +11 more
europepmc +1 more source
Talquetamab: Mechanism of Action, Clinical, and Translational Science. [PDF]
Wang Y +10 more
europepmc +1 more source
Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report. [PDF]
Yang Q +5 more
europepmc +1 more source
Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis. [PDF]
Huang ZY, Liu XL, Li T, Luo CH.
europepmc +1 more source
Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma. [PDF]
Iriuchishima H +6 more
europepmc +1 more source
Treatment with Daratumumab in Combination with Glucocorticosteroids as First-Line Treatment Achieves a Complete Remission for a Patient with Multiple Myeloma and Resolves Neutropenia: A Case Report. [PDF]
Mettias S +3 more
europepmc +1 more source

